Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18

Wang,Yuxia; Ji,Mingli; Chen,Liping; Wu,Xinjun; Wang,Lei

doi:10.3892/etm.2013.1287

November 2013 Volume 6 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2013 Volume 6 Issue 5

Full Size Image

Article

Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18

Authors:
- Yuxia Wang
- Mingli Ji
- Liping Chen
- Xinjun Wu
- Lei Wang
View Affiliations / Copyright

Affiliations: Department of Pathophysiology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China, Department of General Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China
Pages: 1322-1326
|
Published online on: September 4, 2013

https://doi.org/10.3892/etm.2013.1287
Expand metrics +

Abstract

It has been demonstrated that breviscapine is able to treat coronary disease and reduce the inflammatory response; however, there are no relevant reports concerning its effects on the expression of inflammatory factors in acute lung injury induced by left heart ischemic reperfusion and the underlying mechanisms. In this study, we created a left heart ischemia‑reperfusion model in rats to investigate the effects of breviscapine on the expression of interleukin 18 (IL-18) and intercellular adhesion molecule-1 (ICAM-1), as well as to determine the possible mechanisms involved in the protective effects of breviscapine on respiratory function. The left heart ischemia‑reperfusion model was created by ligating the anterior descending branch of the coronary artery for 30 mins followed by reperfusion. Rats in the treatment group (TG) were treated with breviscapine (10 mg/kg) and the rats in the control group (CG) received normal saline. Ten rats in the two groups were sacrificed at three points: 30 min after ligating (T1), 30 min after reperfusion (T2) and 60 min after reperfusion (T3). A respiration curve was produced and the arterial partial pressure of oxygen (PaO2) was measured for all rats. Additionally, the expression levels of IL-18 and ICAM-1 were determined and the correlation between IL-18 and ICAM-1 expression in lung tissue was analyzed. The level of IL-18 in peripheral blood and bronchialalveolar lavage fluid (BALF) was also measured. The respiration amplitude was lower and the duration time was shorter in the TG rats than in the CG rats at T1, T2 and T3. The expression levels of IL-18 and ICAM-1 in the TG group were clearly reduced. The level of IL-18 in the peripheral blood and BALF was downregulated following the administration of breviscapine. These results demonstrate that breviscapine inhibits the expression of IL-18 and ICAM-1, thereby protecting the lungs from inflammatory cascade responses.

View Figures

View References

1.	Ji M, Qian Z, Song X and Wang Y: An animal model of acute lung injury induced by left heart ischemia-reperfusion. Chin J Pathophysiol. 27:1453–1456. 2011.(In Chinese).
2.	van de Veerdonk FL, Netea MG, Dinarello CA and Joosten LA: Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 32:110–116. 2011.
3.	Chen J, Zhao YH, Liu XL, Chen XL, Li J, Lian QQ, et al: Effects of breviscapine on pulmonary inflammatory response and lung injury in children undergoing open heart surgery. J Asian Nat Prod Res. 14:270–275. 2012. View Article : Google Scholar : PubMed/NCBI
4.	Xie WX, Yue LM and Song HL: Protective effect of breviscapine on cardiac function in children after cardiopulmonary bypass undergoing open heart surgery. Zhongguo Zhong Xi Yi Jie He Za Zhi. 30:264–267. 2010.(In Chinese).
5.	Zhang MY, Fan SJ, Li LP, Wu BY and Wang Y: The anti-injury effect of breviscapine injection on the hypoxic ischemic brain damage of neonatal rats and the expression of Bcl-2 and Bax. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 27:196–200. 2011.(In Chinese).
6.	Barker BR, Taxman DJ and Ting JP: Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol. 23:591–597. 2011.
7.	Volin MV and Koch AE: Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res. 31:745–741. 2011. View Article : Google Scholar : PubMed/NCBI
8.	Nishimoto N: Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther. 87:483–487. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Pedroza M, Schneider DJ and Karmouty-Quintana H: Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS One. 6:e226672011. View Article : Google Scholar : PubMed/NCBI
10.	Yokomura I, Iwasaki Y, Nagata K, et al: Role of intercellular adhesion molecule-1 in acute lung injury induced by candidemia. Exp Lung Res. 27:417–411. 2001. View Article : Google Scholar : PubMed/NCBI
11.	Porter JC and Hall A: Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium. FASEB J. 23:492. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Gustapane M, Cardillo MT, Biasillo G and Biasucci LM: Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome. Recenti Prog Med. 102:447–450. 2011.(In Italian).
13.	Ramirez P, Ferrer M, Gimeno R, et al: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med. 37:1691–1615. 2009. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Related Articles